Israeli oncologists and radiotherapists have successfully implemented the latest treatment option for pancreatic cancer called ONCOSIL. It helps patients with unresectable tumors that have spread to nearby organs and structures. The treatment has already demonstrated high effectiveness.
Pancreatic cancer remains one of the most aggressive types of cancer, and it is often detected at metastatic stages, which significantly reduces patients’ survival rates. Involvement of major blood vessels and organs in the tumor makes surgical removal impossible, and the only treatment option in such cases has been chemotherapy, sometimes in combination with radiation therapy. However, the recently approved ONCOSIL method allows for more effective and gentle treatment.
The essence of the method lies in the direct introduction of a special radioactive substance into the tumor, which selectively damages the cancerous tissue without causing as much harm to the surrounding healthy organs as systemic therapy does. The procedure is performed under the control of endoscopic ultrasound and does not require hospitalization. Furthermore, the treatment is reduced to a single injection due to the use of a high dose of selective radiation.
The effectiveness of the new method has been proven in a controlled study: in combination with chemotherapy, ONCOSIL reduced the size of tumors, and in many patients, to such an extent that they became resectable, allowing doctors to completely remove the neoplasm through surgery.
To date, over 200 individuals worldwide have undergone treatment using this innovative method. ONCOSIL has been approved for use in Israel, Europe, Australia, and New Zealand. Recently, a revolutionary treatment was successfully administered to a 68-year-old patient at the Hadassah Medical Center in Israel.
